Immune Checkpoint Inhibitors

Immune checkpoint inhibitors are a type of cancer therapy that increases our own immune system’s ability to detect and destroy cancer cells.

Immune checkpoint inhibitors are used to treat many types of cancer, such as melanoma, non-small cell lung cancer, bladder cancer, renal cell carcinoma, breast cancer, and Hodgkin lymphoma.

Common immune checkpoint inhibitors include: pembrolizumab (Keytruda), nivolumab (Opdivo), ipilimumab (Yervoy), durvalumab (Imfinzi), atezolizumab (Tecentriq). 

Authors: Christopher Berg, MD and Anjali Rao, MD
Medical Reviewers: Courtney Campbell, MD; Carrie Lenneman, MD; Lavanya Kondapalli, MD